Qolab, a Santa Barbara-based startup building superconducting quantum processors, announced a $54.2 million Series B financing on July 2, 2026, led by UC Investments with participation from existing backers WARF, Octave Ventures and Phoenix Venture Partners. Co-founder and CTO John Martinis, who shared the 2025 Nobel Prize in Physics, unveiled the round in person at the Lindau Nobel Laureate Meeting, a marquee gathering of physics researchers and Nobel laureates.
The round's structure is notable: alongside new cash, it includes the conversion of $12.6 million in existing convertible securities plus a fresh commitment for $10 million in additional convertible securities, meaning a meaningful share of the total reflects existing believers increasing their exposure rather than purely new investors entering the cap table.
Qolab plans to use the proceeds to fund semiconductor fabrication collaborations and scale up manufacturing capacity, a deliberate shift in emphasis from lab-stage prototyping toward the kind of repeatable production process that fault-tolerant quantum computing will eventually require at commercial scale. The company works closely with Lawrence Berkeley National Laboratory's Quantum Systems Accelerator and researchers at UC Santa Barbara, keeping its technical roadmap tightly coupled to frontier academic quantum research.
UC Investments leading the round is itself a signal worth noting: large institutional allocators, rather than only specialist deep-tech or quantum-focused venture funds, are now willing to lead early-stage quantum hardware rounds directly, a pattern that has become more common as quantum computing shifts from a purely speculative long-horizon bet toward a category with clearer, if still distant, commercial milestones.
For deep-tech investors, Qolab's round is another data point in a broader 2026 pattern of quantum computing hardware startups raising substantial rounds specifically tied to manufacturing and fabrication scale-up rather than pure research, following a similar path taken by other quantum hardware players earlier this year. For founders in adjacent hard-science fields, a sitting Nobel laureate personally leading fundraising and technical strategy is a reminder of how much scientific credibility can still move institutional capital in categories where the underlying technology remains years from broad commercial deployment.
What to watch: how quickly Qolab's semiconductor fabrication partnerships translate into increased processor qubit counts or coherence times, whether UC Investments' direct leadership on this round becomes a template for other university endowments backing quantum hardware, and how Qolab's manufacturing scale-up progress compares with competing superconducting-qubit approaches from larger, better-capitalized rivals.